A Study of the Effect of Time-of-day of Training on Chronic Patellar Tendinopathy
TENDOTIME
Tendinopathy: Optimal Time for Management Through Exercise (TENDOTIME) - a Randomised Controlled Study Comparing Targeted Training Performed Morning and Late Afternoon in a 12-week Intervention Program on Chronic Patellar Tendinopathy
1 other identifier
interventional
70
1 country
1
Brief Summary
The study is a 12-week human study where 60 participants with chronic patellar tendinopathy (more than 3 months symptoms duration) are randomised to undergo 12 weeks of targeted resistance exercise either in the morning or in the late afternoon. The overall aim is to investigate when the best time of the day to perform muscular strength training therapy towards tendinopathy is. The study will also include 10 healthy controls who will not perform any exercise training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2024
CompletedStudy Start
First participant enrolled
January 10, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 22, 2024
January 1, 2024
11 months
January 10, 2024
January 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Patient perception VISA-P
Change in Victorian Institute of Sports Assessment - patella (VISA-P) total score. The VISA-P asses symptoms, function and the ability to participate in sport. It consists of 8 questions, with a maximum score of 100 indicating the person is asymptomatic and fully per-forming and lower scores indicating more symptoms and limitations of function and activity.
Change from baseline at week 12.
Secondary Outcomes (16)
Patient perception VISA-P truncated
Change from baseline at week 12 and 52.
Patient perception VISA-P
Change from baseline at week 52.
Self-reported improvement (GROC)
Change from baseline at week 12 and 52.
Self-reported satisfaction (PASS)
Change from baseline at week 12 and 52.
Counter movement jump height
Change from baseline at week 52.
- +11 more secondary outcomes
Study Arms (3)
Morning exercise
EXPERIMENTALThree sessions per week of targeted resistance exercise targeting the quadriceps muscles performed between 6:00 and 8:00 for 12 weeks.
Late afternoon exercise
EXPERIMENTALThree sessions per week of targeted resistance exercise targeting the quadriceps muscles performed between 16:00 and 18:00 for 12 weeks.
Healthy control
NO INTERVENTIONHealthy individuals without tendinopathy as controls for the transcriptomics and proteomics analyses.
Interventions
The exercise will be started at 60% of 1 repetition maximum (RM) and progressed to 75% of 1 RM during the first 3 weeks and maintained throughout the intervention period. The exercise will be performed slowly (6 s/ repetition).
Eligibility Criteria
You may qualify if:
- Sports active men and women
- Age (18-55) years old
- BMI (18.5-30)
- Uni- or bilateral patellar tendinopathy
- Symptom onset \>90 days ago
You may not qualify if:
- Patellar tendinopathy longer than 24 months
- Previous surgery in the knee on the ipsilateral side
- Corticosteroid injection in the patellar tendon on the ipsilateral side within the last 6 months
- Any confounding diagnosis to the knee joint
- Known arthritis
- Known diabetes
- Known rheumatic disorders
- Inability to follow rehabilitation or complete follow-ups
- Enrolled in a resistance based-rehabilitation program for the affected patellar tendon within the previous 3 months
- Have an occupation where it is not feasible to avoid pain provoking tasks
- Pregnancy
- Have sleeping disorders or disruptions, e.g., night shift work
- Use of medicines or supplements known to affect collagen synthesis or sleep
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Medicine Copenhagen
Copenhagen NV, Capital Region, 2400, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Researcher
Study Record Dates
First Submitted
January 10, 2024
First Posted
January 22, 2024
Study Start
January 10, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
January 22, 2024
Record last verified: 2024-01